Chatziralli I, Dimitriou E, Chatzirallis A, Aissopou E, Theodossiadis P. Efficacy and safety of Resvega in diabetic macular edema: preliminary results of a pilot study. Acta Ophthalmologica. 2019;97.

Chatziralli IP, Sivaprasad S. Anti-Vascular Endothelial Growth Factor Therapy and Cardiovascular Disease Risk. In: Diabetic Retinopathy and Cardiovascular Disease. Vol. 27. Karger Publishers; 2019. pp. 100–105.

Chatziralli I, Theodossiadis P, Theodossiadis G. New observations regarding the assessment of cilioretinal arteries coexistence with optic disc pit. In: Seminars in ophthalmology. Vol. 34. Taylor & Francis; 2019. pp. 375–379.

Karagiannis D, Parikakis E, Kontomichos L, Batsos G, Chatziralli I. The effect of eplerenone in chronic central serous chorioretinopathy refractory to photodynamic therapy. In: Seminars in ophthalmology. Vol. 34. Taylor & Francis; 2019. pp. 436–441.

Chatziralli I, Theodossiadis G, Dimitriou E, Kazantzis D, Theodossiadis P. Macular edema after successful pars plana vitrectomy for rhegmatogenous retinal detachment: factors affecting edema development and considerations for treatment. Ocular immunology and inflammation. 2019:1–6.

Bontzos G, Garnavou-Xirou C, Xirou T, Gkizis I, Kabanarou S, Chatziralli I. Do macular OCT-A measures correlate with functional outcomes in diabetic patients?. Acta Ophthalmologica. 2019;97.

Chatziralli I. Optical coherence tomography biomarkers for idiopathic epiretinal membrane after pars plana vitrectomy. Acta Ophthalmologica. 2019;97.

Chatzara A, Chronopoulou I, Theodossiadis G, Theodossiadis P, Chatziralli I. XEN implant for glaucoma treatment: a review of the literature. In: Seminars in ophthalmology. Vol. 34. Taylor & Francis; 2019. pp. 93–97.

Peponis V, Kontomichos L, Chatziralli I, Kontadakis G, Parikakis E. Late onset corneal haze after corneal cross-linking for progressive keratoconus. American journal of ophthalmology case reports. 2019;14:64–66.

Sfiniadaki E, Tsiara I, Theodossiadis P, Chatziralli I. Ocular manifestations of granulomatosis with polyangiitis: a review of the literature. Ophthalmology and therapy. 2019;8:227–234.

Chatziralli I, Dimitriou E, Theodossiadis G, Chatzirallis A, Kazantzis D, Theodossiadis P. Treatment of macular edema after pars plana vitrectomy for idiopathic epiretinal membrane using intravitreal dexamethasone implant: long-term outcomes. Ophthalmologica. 2019;242:16–21.

Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, Culpepper WJ, Dorsey RE, Elbaz A, Ellenbogen RG, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019;18:459–480.

Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, Culpepper WJ, Dorsey E, Elbaz A, Ellenbogen RG, et al. Global, regional and national burden of neurological. Disorders, 1990-2016: a systematic analysis for the Global Study of the burden of disease 2016. 2019.

Chatziralli I, Saitakis G, Dimitriou E, Chatzirallis A, Stoungioti S, Theodossiadis G, Theodossiadis P. Angioid streaks: a comprehensive review from pathophysiology to treatment. Retina. 2019;39:1–11.

Rouvas A, Chatziralli I, Androu A, Mpougatsou P, Alonistiotis D, Douvali M, Kabanarou SA, Theodossiadis P. Ranibizumab versus aflibercept for the treatment of vascularized pigment epithelium detachment due to age-related macular degeneration. International ophthalmology. 2019;39:431–440.